Genetic Abnormality in B6 Metabolism and Game-Changing Breast Cancer Drug

This chapter delves into a caller's elevated B6 levels due to a genetic abnormality, discussing the MTHFR gene's impact. It also introduces a new tablet drug for hormone-positive breast cancer, available on the PBS, with insights on its efficacy and common side effects.